Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 27080 | 196 | 43.9 | 89% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 2982 | 2124 | ENDOCRINE POLYPEPTIDE CANC//LHRH RECEPTOR//SECT EXPT MED |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ENDOCRINE POLYPEPTIDE CANC | Address | 35 | 37% | 39% | 77 |
| 2 | GHRH ANTAGONISTS | Author keyword | 23 | 86% | 6% | 12 |
| 3 | GHRH ANTAGONIST | Author keyword | 22 | 81% | 7% | 13 |
| 4 | GROWTH HORMONE RELEASING HORMONE ANTAGONIST | Author keyword | 12 | 86% | 3% | 6 |
| 5 | GH RH ANTAGONISTS | Author keyword | 11 | 78% | 4% | 7 |
| 6 | SECT EXPT MED | Address | 7 | 21% | 15% | 30 |
| 7 | GROWTH HORMONE RELEASING HORMONE ANTAGONISTS | Author keyword | 6 | 100% | 2% | 4 |
| 8 | MZ 4 71 | Author keyword | 6 | 100% | 2% | 4 |
| 9 | S FLORIDA VET AFFAIRS FDN EDUC | Address | 5 | 63% | 3% | 5 |
| 10 | GHRH RECEPTORS | Author keyword | 4 | 67% | 2% | 4 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | GHRH ANTAGONISTS | 23 | 86% | 6% | 12 | Search GHRH+ANTAGONISTS | Search GHRH+ANTAGONISTS |
| 2 | GHRH ANTAGONIST | 22 | 81% | 7% | 13 | Search GHRH+ANTAGONIST | Search GHRH+ANTAGONIST |
| 3 | GROWTH HORMONE RELEASING HORMONE ANTAGONIST | 12 | 86% | 3% | 6 | Search GROWTH+HORMONE+RELEASING+HORMONE+ANTAGONIST | Search GROWTH+HORMONE+RELEASING+HORMONE+ANTAGONIST |
| 4 | GH RH ANTAGONISTS | 11 | 78% | 4% | 7 | Search GH+RH+ANTAGONISTS | Search GH+RH+ANTAGONISTS |
| 5 | GROWTH HORMONE RELEASING HORMONE ANTAGONISTS | 6 | 100% | 2% | 4 | Search GROWTH+HORMONE+RELEASING+HORMONE+ANTAGONISTS | Search GROWTH+HORMONE+RELEASING+HORMONE+ANTAGONISTS |
| 6 | MZ 4 71 | 6 | 100% | 2% | 4 | Search MZ+4+71 | Search MZ+4+71 |
| 7 | GHRH RECEPTORS | 4 | 67% | 2% | 4 | Search GHRH+RECEPTORS | Search GHRH+RECEPTORS |
| 8 | SV1 | 3 | 57% | 2% | 4 | Search SV1 | Search SV1 |
| 9 | GH RH | 2 | 44% | 2% | 4 | Search GH+RH | Search GH+RH |
| 10 | BOMBESIN GRP ANTAGONIST | 2 | 67% | 1% | 2 | Search BOMBESIN+GRP+ANTAGONIST | Search BOMBESIN+GRP+ANTAGONIST |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | GH RH | 69 | 93% | 13% | 26 |
| 2 | IN VIVO PROLIFERATION | 32 | 62% | 17% | 33 |
| 3 | ANTAGONISTIC ANALOGS | 18 | 83% | 5% | 10 |
| 4 | GHRH | 8 | 33% | 10% | 20 |
| 5 | GHRH RECEPTORS | 8 | 100% | 3% | 5 |
| 6 | GHRH ANTAGONIST | 4 | 75% | 2% | 3 |
| 7 | GHRH ANTAGONISTS | 3 | 100% | 2% | 3 |
| 8 | VIVO PROLIFERATION | 3 | 100% | 2% | 3 |
| 9 | SUPERFUSION SYSTEM | 2 | 33% | 3% | 6 |
| 10 | NEGATIVE BREAST CANCERS | 2 | 44% | 2% | 4 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer | 2008 | 32 | 74 | 64% |
| Growth hormone-releasing hormone: not only a neurohormone | 2011 | 16 | 73 | 37% |
| New approaches to the therapy of various tumors based on peptide analogues | 2008 | 47 | 63 | 27% |
| Extrapituitary effects of the growth hormone-releasing hormone | 2005 | 32 | 86 | 55% |
| Endocrine and antineoplastic actions of growth hormone-releasing hormone antagonists | 2008 | 4 | 83 | 64% |
| Growth hormone-releasing hormone and extra-pituitary tumorigenesis: therapeutic and diagnostic applications of growth hormone-releasing hormone antagonists | 2003 | 22 | 73 | 52% |
| Antineoplastic Action of Growth Hormone-Releasing Hormone (GHRH) Antagonists | 2012 | 0 | 68 | 66% |
| Antagonistic analogs of growth hormone-releasing hormone: New potential antitumor agents | 1999 | 54 | 45 | 31% |
| Hypothalamic hormones and cancer | 2001 | 152 | 138 | 12% |
| New Agonist- and Antagonist-based Treatment Approaches for Advanced Prostate Cancer | 2012 | 5 | 60 | 17% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ENDOCRINE POLYPEPTIDE CANC | 35 | 37% | 39% | 77 |
| 2 | SECT EXPT MED | 7 | 21% | 15% | 30 |
| 3 | S FLORIDA VET AFFAIRS FDN EDUC | 5 | 63% | 2.6% | 5 |
| 4 | SECT EXPTL MED | 1 | 100% | 1.0% | 2 |
| 5 | SOUTH FLORIDA VET AFFAIRS FDN EDUC | 1 | 100% | 1.0% | 2 |
| 6 | GEN ENDOCRINOL SURG | 1 | 30% | 1.5% | 3 |
| 7 | POLYPEPTIDE CANC | 1 | 40% | 1.0% | 2 |
| 8 | HEMATOL ONCOL ENDOCRINOL | 1 | 22% | 2.0% | 4 |
| 9 | MILLAR MED | 1 | 50% | 0.5% | 1 |
| 10 | S FLORIDA VA FDN EDUC | 1 | 50% | 0.5% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000267446 | LHRH RECEPTOR//AN 152//ENDOCRINE POLYPEPTIDE CANC |
| 2 | 0.0000205532 | GROWTH HORMONE RELEASING HORMONE//GHRH//GROWTH HORMONE RELEASING PEPTIDES |
| 3 | 0.0000094426 | BOMBESIN//GASTRIN RELEASING PEPTIDE//GASTRIN RELEASING PEPTIDE RECEPTOR |
| 4 | 0.0000087428 | OSTEOBLASTIC METASTASIS//3 D COLLAGEN//AHTO 7 |
| 5 | 0.0000077702 | PACAP//PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE//PITUITARY ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE PACAP |
| 6 | 0.0000070975 | IGF 1R//INSULIN LIKE GROWTH FACTOR 1 RECEPTOR//IGF IR |
| 7 | 0.0000069282 | NOOPEPT//CYCLOPROLYLGLYCINE//GVS 111 |
| 8 | 0.0000059851 | CANCER PREVENTION EFFICACY//INVOLUCRIN EXPRESSION//CELLULAR MOL TOXICOL PROGRAM |
| 9 | 0.0000059439 | EDWARD R MADIGAN 207//BIOACTIVE PROLACTIN//THYMUS |
| 10 | 0.0000054684 | HUHS1015//CHRONIC PROSTATIC INFLAMMATION//NAFTOPIDIL |